Annual Cash & Cash Equivalents
$238.36 M
+$10.47 M+4.59%
June 30, 2024
Summary
- As of February 26, 2025, RMD annual cash & cash equivalents is $238.36 million, with the most recent change of +$10.47 million (+4.59%) on June 30, 2024.
- During the last 3 years, RMD annual cash & cash equivalents has fallen by -$56.92 million (-19.28%).
- RMD annual cash & cash equivalents is now -73.68% below its all-time high of $905.73 million, reached on June 30, 2014.
Performance
RMD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$521.94 M
+$95.58 M+22.42%
December 31, 2024
Summary
- As of February 26, 2025, RMD quarterly cash and cash equivalents is $521.94 million, with the most recent change of +$95.58 million (+22.42%) on December 31, 2024.
- Over the past year, RMD quarterly cash and cash equivalents has stayed the same.
- RMD quarterly cash and cash equivalents is now -48.46% below its all-time high of $1.01 billion, reached on March 31, 2013.
Performance
RMD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RMD Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.6% | 0.0% |
| 3 y3 years | -19.3% | +168.4% |
| 5 y5 years | +62.0% | +155.7% |
RMD Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.3% | +4.6% | at high | +168.4% |
| 5 y | 5-year | -48.5% | +62.0% | at high | +168.4% |
| alltime | all time | -73.7% | >+9999.0% | -48.5% | >+9999.0% |
ResMed Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $521.94 M(+22.4%) |
| Sep 2024 | - | $426.36 M(+78.9%) |
| Jun 2024 | $238.36 M(+4.6%) | $238.36 M(+0.2%) |
| Mar 2024 | - | $237.91 M(+13.2%) |
| Dec 2023 | - | $210.25 M(+0.5%) |
| Sep 2023 | - | $209.10 M(-8.2%) |
| Jun 2023 | $227.89 M(-16.7%) | $227.89 M(-0.0%) |
| Mar 2023 | - | $227.89 M(-10.0%) |
| Dec 2022 | - | $253.20 M(+22.2%) |
| Sep 2022 | - | $207.16 M(-24.3%) |
| Jun 2022 | $273.71 M(-7.3%) | $273.71 M(+35.7%) |
| Mar 2022 | - | $201.77 M(+3.8%) |
| Dec 2021 | - | $194.48 M(-29.6%) |
| Sep 2021 | - | $276.15 M(-6.5%) |
| Jun 2021 | $295.28 M(-36.2%) | $295.28 M(+28.0%) |
| Mar 2021 | - | $230.63 M(-9.9%) |
| Dec 2020 | - | $255.87 M(-39.3%) |
| Sep 2020 | - | $421.41 M(-9.0%) |
| Jun 2020 | $463.16 M(+214.8%) | $463.16 M(+31.3%) |
| Mar 2020 | - | $352.86 M(+72.9%) |
| Dec 2019 | - | $204.09 M(+18.6%) |
| Sep 2019 | - | $172.15 M(+17.0%) |
| Jun 2019 | $147.13 M(-22.0%) | $147.13 M(+0.4%) |
| Mar 2019 | - | $146.51 M(-2.0%) |
| Dec 2018 | - | $149.47 M(-35.1%) |
| Sep 2018 | - | $230.19 M(+22.0%) |
| Jun 2018 | $188.70 M(-77.0%) | $188.70 M(-73.2%) |
| Mar 2018 | - | $704.28 M(-18.0%) |
| Dec 2017 | - | $858.90 M(+5.9%) |
| Sep 2017 | - | $811.10 M(-1.3%) |
| Jun 2017 | $821.93 M(+12.4%) | $821.93 M(-0.6%) |
| Mar 2017 | - | $827.31 M(+5.0%) |
| Dec 2016 | - | $788.15 M(+0.8%) |
| Sep 2016 | - | $781.66 M(+6.9%) |
| Jun 2016 | $731.43 M(+2.0%) | $731.43 M(+1.8%) |
| Mar 2016 | - | $718.50 M(+9.1%) |
| Dec 2015 | - | $658.80 M(-19.9%) |
| Sep 2015 | - | $822.05 M(+14.6%) |
| Jun 2015 | $717.25 M(-20.8%) | $717.25 M(-17.2%) |
| Mar 2015 | - | $866.33 M(-1.6%) |
| Dec 2014 | - | $880.70 M(-0.1%) |
| Sep 2014 | - | $881.69 M(-2.7%) |
| Jun 2014 | $905.73 M(+3.4%) | $905.73 M(-3.5%) |
| Mar 2014 | - | $938.56 M(-3.5%) |
| Dec 2013 | - | $972.67 M(-0.4%) |
| Sep 2013 | - | $976.57 M(+11.5%) |
| Jun 2013 | $876.05 M(+8.2%) | $876.05 M(-13.5%) |
| Mar 2013 | - | $1.01 B(+5.7%) |
| Dec 2012 | - | $958.28 M(+7.6%) |
| Sep 2012 | - | $890.63 M(+10.0%) |
| Jun 2012 | $809.54 M(+10.1%) | $809.54 M(+4.3%) |
| Mar 2012 | - | $776.07 M(+7.3%) |
| Dec 2011 | - | $723.23 M(+18.6%) |
| Sep 2011 | - | $610.06 M(-17.0%) |
| Jun 2011 | $735.27 M(+50.4%) | $735.27 M(+9.5%) |
| Mar 2011 | - | $671.70 M(+9.0%) |
| Dec 2010 | - | $616.20 M(+14.1%) |
| Sep 2010 | - | $540.00 M(+10.5%) |
| Jun 2010 | $488.78 M | $488.78 M(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $520.94 M(+15.4%) |
| Dec 2009 | - | $451.43 M(-5.5%) |
| Sep 2009 | - | $477.82 M(+15.0%) |
| Jun 2009 | $415.65 M(+29.5%) | $415.65 M(+27.1%) |
| Mar 2009 | - | $327.07 M(+2.1%) |
| Dec 2008 | - | $320.49 M(+6.1%) |
| Sep 2008 | - | $302.07 M(-5.9%) |
| Jun 2008 | $321.08 M(+24.5%) | $321.08 M(+4.4%) |
| Mar 2008 | - | $307.49 M(+10.4%) |
| Dec 2007 | - | $278.50 M(+10.8%) |
| Sep 2007 | - | $251.31 M(-2.5%) |
| Jun 2007 | $257.79 M(+17.4%) | $257.79 M(+7.4%) |
| Mar 2007 | - | $240.11 M(+3.2%) |
| Dec 2006 | - | $232.67 M(+15.7%) |
| Sep 2006 | - | $201.16 M(-8.4%) |
| Jun 2006 | $219.54 M(+54.4%) | $219.54 M(+32.1%) |
| Mar 2006 | - | $166.16 M(+18.4%) |
| Dec 2005 | - | $140.28 M(+8.1%) |
| Sep 2005 | - | $129.73 M(-8.8%) |
| Jun 2005 | $142.19 M(+10.3%) | $142.19 M(+4.0%) |
| Mar 2005 | - | $136.70 M(-4.5%) |
| Dec 2004 | - | $143.07 M(+1.0%) |
| Sep 2004 | - | $141.62 M(+9.9%) |
| Jun 2004 | $128.91 M(+12.6%) | $128.91 M(+12.5%) |
| Mar 2004 | - | $114.57 M(+6.6%) |
| Dec 2003 | - | $107.46 M(+2.7%) |
| Sep 2003 | - | $104.68 M(-8.6%) |
| Jun 2003 | $114.49 M(+57.1%) | $114.49 M(+22.2%) |
| Mar 2003 | - | $93.72 M(+13.6%) |
| Dec 2002 | - | $82.47 M(+12.1%) |
| Sep 2002 | - | $73.57 M(+1.0%) |
| Jun 2002 | $72.86 M(+81.5%) | $72.86 M(+29.6%) |
| Mar 2002 | - | $56.23 M(-12.2%) |
| Dec 2001 | - | $64.05 M(+6.0%) |
| Sep 2001 | - | $60.44 M(+50.6%) |
| Jun 2001 | $40.14 M(+119.9%) | $40.14 M(+63.4%) |
| Mar 2001 | - | $24.57 M(+45.8%) |
| Dec 2000 | - | $16.86 M(+23.8%) |
| Sep 2000 | - | $13.62 M(-25.4%) |
| Jun 2000 | $18.25 M(+64.4%) | $18.25 M(+11.6%) |
| Mar 2000 | - | $16.36 M(+42.2%) |
| Dec 1999 | - | $11.50 M(+6.5%) |
| Sep 1999 | - | $10.80 M(-2.7%) |
| Jun 1999 | $11.10 M(-28.4%) | $11.10 M(+2.8%) |
| Mar 1999 | - | $10.80 M(-20.6%) |
| Dec 1998 | - | $13.60 M(-17.6%) |
| Sep 1998 | - | $16.50 M(+6.5%) |
| Jun 1998 | $15.50 M(+70.3%) | $15.50 M(+31.4%) |
| Mar 1998 | - | $11.80 M(+55.3%) |
| Dec 1997 | - | $7.60 M(-43.3%) |
| Sep 1997 | - | $13.40 M(+47.3%) |
| Jun 1997 | $9.10 M(+65.5%) | $9.10 M(+5.8%) |
| Mar 1997 | - | $8.60 M(0.0%) |
| Dec 1996 | - | $8.60 M(+32.3%) |
| Sep 1996 | - | $6.50 M(+18.2%) |
| Jun 1996 | $5.50 M(+66.7%) | $5.50 M(+37.5%) |
| Mar 1996 | - | $4.00 M(+21.2%) |
| Jun 1995 | $3.30 M(-10.8%) | $3.30 M(-10.8%) |
| Jun 1994 | $3.70 M(+117.6%) | $3.70 M(+117.6%) |
| Jun 1993 | $1.70 M | $1.70 M |
FAQ
- What is ResMed annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ResMed?
- What is ResMed annual cash & cash equivalents year-on-year change?
- What is ResMed quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ResMed?
- What is ResMed quarterly cash and cash equivalents year-on-year change?
What is ResMed annual cash & cash equivalents?
The current annual cash & cash equivalents of RMD is $238.36 M
What is the all time high annual cash & cash equivalents for ResMed?
ResMed all-time high annual cash & cash equivalents is $905.73 M
What is ResMed annual cash & cash equivalents year-on-year change?
Over the past year, RMD annual cash & cash equivalents has changed by +$10.47 M (+4.59%)
What is ResMed quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RMD is $521.94 M
What is the all time high quarterly cash and cash equivalents for ResMed?
ResMed all-time high quarterly cash and cash equivalents is $1.01 B
What is ResMed quarterly cash and cash equivalents year-on-year change?
Over the past year, RMD quarterly cash and cash equivalents has changed by $0.00 (0.00%)